Charles River Discovery Services is licensed to carry out biodistribution studies with C14- and H3-labeled molecules. Biodistribution studies with C- and H-labeled molecules help determine the targeting and tumor specificity of a test agent. On-site determination of radiolabeled levels in samples is possible.
We also have the capability of administering radiation as a therapy using a Faxitron Model CP-160 instrument. This capability enables the use of radiation for:
- Combination radiation/chemotherapy
- Myeloablation
- In vitro applications
For more information about our radiation services, please contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.
|
|
|
biodistribution, biodistribution studies, C14 labeled, H3-labeled, C-labeled, H-labeled, tumor, radiolabeled, radioactivity, radiation, Myeloablation
Biodistribution Studies with C- and H-labeled Molecules | Charles River
Charles River Discovery Services is licensed to carry out biodistribution studies with C14- and H3-labeled molecules. Biodistribution studies with C- and H-labeled molecules help determine the targeting and tumor specificity of a test agent.